Clinical Trials
3 trialsNCT04865679 2026-06-03
REPOSE-XLâ„
Axogen Corporation
Phase NA Active not recruiting
NCT07484022 2026-06-03
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Generate Biomedicines
Phase 1 Recruiting
NCT06848348 2026-05-29
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Dogwood Therapeutics Inc.
Phase 2 Recruiting